RBC Capital Upgrades ISTA Pharmaceuticals (ISTA) to Outperform
Tweet
Share
E-mailGet Alerts ISTA Hot Sheet
Price: $9.09 --0%
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 22 | New: 15
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 22 | New: 15
Join SI Premium – FREE
RBC Capital upgraded ISTA Pharmaceuticals (NASDAQ: ISTA) from Sector Perform to Outperform.
For more ratings news on ISTA Pharmaceuticals click here and for the rating history of ISTA Pharmaceuticals click here.
Shares of ISTA Pharmaceuticals closed at $10.04 yesterday.
For more ratings news on ISTA Pharmaceuticals click here and for the rating history of ISTA Pharmaceuticals click here.
Shares of ISTA Pharmaceuticals closed at $10.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Susquehanna Upgrades CSX (CSX) to Positive
- RBC Capital Starts Denison Mines (DML:CN) (DNN) at Outperform
- BofA Securities Upgrades AptarGroup (ATR) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
